"SUBJECT_ID"	"GenSig:sen"	"GenSig:res"	"Feature.sensitive"	"Feature.resistant"	"dGensig"	"mySlope"	"TEST_SET"	"PatientID"	"BGUSCT"	"Erstatus"	"Prstatus"	"HER2status"	"TreatmentArm"	"DrugTreatment"	"Age"	"ECOG"	"Inflammatory"	"Menopausalstatus"	"pCR_patient"	"pCR_Breast"	"label"	"senlabel"
"GSM1232994"	0.518459918664528	0.142349684153403	11470	17150	0.158114487157746	1.5723673999837	1	"patid: 191"	"bgus.ct: 30.75"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 55"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1232996"	0.297366993101661	0.229612976258677	11470	17150	-0.0341677765716723	1.5723673999837	1	"patid: 131"	"bgus.ct: 30.09"	"er: ER+"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 73"	"ecog: 1"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1232997"	0.489834833300856	0.710969045938373	11470	17150	-0.337051900108359	1.5723673999837	1	"patid: 91"	"bgus.ct: 31.9"	"er: ER+"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 49"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1232998"	0.165635309952401	0.202144029095621	11470	17150	-0.0816827439615463	1.5723673999837	1	"patid: 151"	"bgus.ct: 30.98"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 47"	"ecog: 1"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1232999"	0.434809502136826	0.0947984694800435	11470	17150	0.15334775171099	1.5723673999837	1	"patid: 71"	"bgus.ct: 31.62"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 60"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233000"	1	0.283018735854598	11470	17150	0.297834173218777	1.5723673999837	1	"patid: 111"	"bgus.ct: 29.22"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 53"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233001"	0.600922979652055	0.415670431222121	11470	17150	-0.0282618070693737	1.5723673999837	1	"patid: 41"	"bgus.ct: 29.34"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 44"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233004"	0.578471161357582	0.698290611512848	11470	17150	-0.278787308868558	1.5723673999837	1	"patid: 81"	"bgus.ct: 31.96"	"er: ER+"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 67"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233006"	0.336996026358843	0.194296039429509	11470	17150	0.0168997030660832	1.5723673999837	1	"patid: 21"	"bgus.ct: 31.02"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 51"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233008"	0.379433317382864	0.257527004482997	11470	17150	-0.0136811508933389	1.5723673999837	1	"patid: 381"	"bgus.ct: 30.27"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 64"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233009"	0.466649846576069	0.298923820948303	11470	17150	-0.00180754852189062	1.5723673999837	1	"patid: 321"	"bgus.ct: 30.67"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 50"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233011"	0.13334623243247	0.312082882556024	11470	17150	-0.191777727770545	1.5723673999837	1	"patid: 331"	"bgus.ct: 30.94"	"er: ER+"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 59"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233012"	0.460437199237127	1	11470	17150	-0.596714308693821	1.5723673999837	1	"patid: 301"	"bgus.ct: 31.75"	"er: ER+"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 47"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233017"	0.526728135221588	0.111099387077723	11470	17150	0.188920812300185	1.5723673999837	1	"patid: 221"	"bgus.ct: 29.79"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 60"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233020"	0.435439861129106	0.459786173720993	11470	17150	-0.154293029174047	1.5723673999837	1	"patid: 261"	"bgus.ct: 29.5"	"er: ER+"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 59"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233022"	0.695803649602805	0.383523923993376	11470	17150	0.0497810830029381	1.5723673999837	1	"patid: 241"	"bgus.ct: 31.02"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 54"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233023"	0.49402023244308	0.592688074157024	11470	17150	-0.234999543501959	1.5723673999837	1	"patid: 421"	"bgus.ct: 31.45"	"er: ER+"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 51"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233026"	0.538758953524671	0.103633475765236	11470	17150	0.201676903924654	1.5723673999837	1	"patid: 401"	"bgus.ct: 32.32"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 48"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233027"	0.449629544464982	0.128250765438485	11470	17150	0.133073616353815	1.5723673999837	1	"patid: 511"	"bgus.ct: 30.04"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 52"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233028"	0.61482339655408	0.412776448861577	11470	17150	-0.0183602246269873	1.5723673999837	1	"patid: 451"	"bgus.ct: 31.35"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 64"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233033"	0.337551531926607	0.198450825496207	11470	17150	0.0136919773951027	1.5723673999837	1	"patid: 91"	"bgus.ct: 33.46"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 48"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233034"	0.50778833237241	0.185509738711619	11470	17150	0.115968867336295	1.5723673999837	1	"patid: 101"	"bgus.ct: 30.27"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 53"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233036"	0.509967867345837	0.562629709690449	11470	17150	-0.2010778401474	1.5723673999837	1	"patid: 81"	"bgus.ct: 30.56"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 44"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233037"	0.572716068893228	0.501409461963377	11470	17150	-0.115746135266242	1.5723673999837	1	"patid: 91"	"bgus.ct: 31.75"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 39"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233040"	0.515427385925204	0.29846836677601	11470	17150	0.024753100167277	1.5723673999837	1	"patid: 141"	"bgus.ct: 33.63"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 48"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233041"	0.335384642442065	0.141179917888959	11470	17150	0.0608546962165291	1.5723673999837	1	"patid: 121"	"bgus.ct: 34.27"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 46"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233045"	0.59085471035883	0.107470787747682	11470	17150	0.226396000236709	1.5723673999837	1	"patid: 31"	"bgus.ct: 30.92"	"er: ER+"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 35"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233047"	0.309762601168867	0.435977798138392	11470	17150	-0.20164772161282	1.5723673999837	1	"patid: 491"	"bgus.ct: 32.93"	"er: ER+"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 35"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233048"	0.568981942227301	0.175784138180654	11470	17150	0.157014777769627	1.5723673999837	1	"patid: 441"	NA	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 47"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233050"	0.572228758029939	0.237096612839498	11470	17150	0.107021297202914	1.5723673999837	1	"patid: 421"	"bgus.ct: 33.56"	"er: ER-"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 50"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233052"	0.602003388914379	0.186822118132092	11470	17150	0.165421725878864	1.5723673999837	1	"patid: 301"	"bgus.ct: 33.53"	"er: ER-"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 41"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233053"	0.469484449983764	0.55216439207226	11470	17150	-0.213972450761444	1.5723673999837	1	"patid: 31"	"bgus.ct: 31.82"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 54"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233055"	0.420336025575327	0.321334269436528	11470	17150	-0.0455718202454642	1.5723673999837	1	"patid: 71"	"bgus.ct: 34.81"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 52"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233056"	0.29135943379932	0.348828506117635	11470	17150	-0.137986576801374	1.5723673999837	1	"patid: 91"	"bgus.ct: 34.41"	"er: ER+"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 56"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233058"	0.52706504883881	0.182741057774392	11470	17150	0.128649896094987	1.5723673999837	1	"patid: 801"	"bgus.ct: 32.11"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 45"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233059"	0.60642069665456	0.316769273965024	11470	17150	0.0581419844707587	1.5723673999837	1	"patid: 861"	"bgus.ct: 32.03"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 57"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233061"	0.381095301310047	0.603238225790443	11470	17150	-0.304502688091816	1.5723673999837	1	"patid: 661"	"bgus.ct: 32.34"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 45"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233063"	0.165375586524979	0.214786609855319	11470	17150	-0.0924900178710419	1.5723673999837	1	"patid: 891"	"bgus.ct: 33.73"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 37"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233065"	0.393260746359519	0.303131777492753	11470	17150	-0.0447423107574884	1.5723673999837	1	"patid: 631"	"bgus.ct: 30.06"	"er: ER-"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 42"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233066"	0.093573922397393	0.303144157206035	11470	17150	-0.205578873324273	1.5723673999837	1	"patid: 551"	"bgus.ct: 32.48"	"er: ER+"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 35"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233070"	0.362439145937684	0.148310478443801	11470	17150	0.0693566071117923	1.5723673999837	1	"patid: 41"	"bgus.ct: 30.95"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 55"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233071"	0.727689628365547	0.270909485311761	11470	17150	0.161917421634176	1.5723673999837	1	"patid: 161"	"bgus.ct: 29.49"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 41"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233074"	0.405088590426888	0.990707710307249	11470	17150	-0.618576092537772	1.5723673999837	1	"patid: 121"	"bgus.ct: 29.71"	"er: ER+"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 55"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233076"	0.230926644788623	0.31161196355067	11470	17150	-0.13901410109542	1.5723673999837	1	"patid: 51"	"bgus.ct: 30.42"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 45"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233077"	0	0.47133025986266	11470	17150	-0.39771161964318	1.5723673999837	1	"patid: 61"	"bgus.ct: 0"	"er: ER+"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 58"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233080"	0.526540961627188	0.145232796565092	11470	17150	0.160018367317946	1.5723673999837	1	"patid: 61"	"bgus.ct: 33.24"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 58"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233081"	0.310115232362002	0.654925160695501	11470	17150	-0.386207729156619	1.5723673999837	1	"patid: 141"	"bgus.ct: 32"	"er: ER+"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 46"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233084"	0.522181395979341	0.352713918111561	11470	17150	-0.0173951370970684	1.5723673999837	1	"patid: 81"	"bgus.ct: 33.4"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 36"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233087"	0.34148657368601	0.0991802717369211	11470	17150	0.0995688627637291	1.5723673999837	1	"patid: 11"	"bgus.ct: 32.98"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 52"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: RD"	0	"res"	"other"
"GSM1233088"	0.474055878869814	0.284370485025277	11470	17150	0.0144470805064438	1.5723673999837	1	"patid: 301"	"bgus.ct: 31.52"	"er: ER-"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 41"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233089"	0.198652570453208	0.34623671249685	11470	17150	-0.185550489337028	1.5723673999837	1	"patid: 351"	"bgus.ct: 30.93"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 49"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233090"	0.471276897752174	0.325404430464677	11470	17150	-0.021668969213183	1.5723673999837	1	"patid: 21"	"bgus.ct: 32.69"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 56"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233092"	0.241390054571047	0	11470	17150	0.129541314231967	1.5723673999837	1	"patid: 221"	"bgus.ct: 30.66"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 56"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233094"	0.351081718898968	0.0510571058568622	11470	17150	0.145324719881448	1.5723673999837	1	"patid: 141"	"bgus.ct: 31.51"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 60"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233097"	0.423563100189691	0.186339852805563	11470	17150	0.0700691704524511	1.5723673999837	1	"patid: 61"	"bgus.ct: 31.26"	"er: ER-"	"pr: PR+"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 58"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233099"	0.284090954449462	0.146419966054326	11470	17150	0.0289064908713575	1.5723673999837	1	"patid: 101"	"bgus.ct: 31.83"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 52"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233100"	0.335771349415636	0.0761361423243265	11470	17150	0.11594659348087	1.5723673999837	1	"patid: 111"	"bgus.ct: 32.87"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 46"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233104"	0.59314869503615	0.234815928424473	11470	17150	0.120172381058246	1.5723673999837	1	"patid: 31"	"bgus.ct: 30.83"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 42"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233106"	0.498979938339969	0.193388442091835	11470	17150	0.10459376420299	1.5723673999837	1	"patid: 101"	"bgus.ct: 34.21"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 26"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233111"	0.82855905357948	0.488019712657282	11470	17150	0.032849664329893	1.5723673999837	1	"patid: 21"	"bgus.ct: 31.96"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 76"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233112"	0.369201934296462	0.520986693679561	11470	17150	-0.241480839186208	1.5723673999837	1	"patid: 51"	"bgus.ct: 33.35"	"er: ER+"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 58"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: RD"	0	"res"	"other"
"GSM1233122"	0.280716526924904	0.15188682262224	11470	17150	0.0224826434802466	1.5723673999837	1	"patid: 21"	"bgus.ct: 29.5"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 38"	"ecog: 0"	"inflammatory.brca: yes"	"menopausal.status: pre"	"pcr: pCR"	1	"sen"	"sen"
"GSM1233146"	0.176009847525967	0.0509146502946424	11470	17150	0.0514930826896679	1.5723673999837	1	"patid: 161"	"bgus.ct: 26.6425"	"er: ER-"	"pr: PR-"	"her2: HER2+"	"arm: HER2+ CT H"	"treatment: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year"	"age: 58"	"ecog: 0"	"inflammatory.brca: no"	"menopausal.status: post"	"pcr: pCR"	1	"sen"	"sen"
